{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:17:56Z","timestamp":1790900276010,"version":"4.1.0"},"reference-count":32,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Severe congenital neutropenia (SCN) is characterized by neutropenia, recurrent bacterial infections, and maturation arrest in the bone marrow. Although many cases have mutations in the ELA2 gene encoding neutrophil elastase, a significant proportion remain undefined at a molecular level. A mutation (Leu270Pro) in the gene encoding the Wiskott-Aldrich syndrome protein (WASp) resulting in an X-linked SCN kindred has been reported. We therefore screened the WAS gene in 14 young SCN males with wild-type ELA2 and identified 2 with novel mutations, one who presented with myelodysplasia (Ile294Thr) and the other with classic SCN (Ser270Pro). Both patients had defects of immunologic function including a generalized reduction of lymphoid and natural killer cell numbers, reduced lymphocyte proliferation, and abrogated phagocyte activity. In vitro culture of bone marrow progenitors demonstrated a profound reduction in neutrophil production and increased levels of apoptosis, consistent with an intrinsic disturbance of normal myeloid differentiation as the cause of the neutropenia. Both mutations resulted in increased WASp activity and produced marked abnormalities of cytoskeletal structure and dynamics. Furthermore, these results also suggest a novel cause of myelodysplasia and that male children with myelodysplasia and disturbance of immunologic function should be screened for such mutations.<\/jats:p>","DOI":"10.1182\/blood-2006-01-010249","type":"journal-article","created":{"date-parts":[[2006,6,28]],"date-time":"2006-06-28T01:49:59Z","timestamp":1151459399000},"page":"2182-2189","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":193,"title":["Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia"],"prefix":"10.1182","volume":"108","author":[{"given":"Phil J.","family":"Ancliff","sequence":"first","affiliation":[{"name":"From the Department of Haematology, Great Ormond Street Hospital, London; the Department of Haematology, the Molecular Immunology Unit and the Molecular Haematology Unit, Institute of Child Health, University College London; the Department of Biochemistry, School of Medical Sciences, University of Bristol; and the Randall Division of Cell and Molecular Biophysics, King's College London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Blundell","sequence":"additional","affiliation":[{"name":"From the Department of Haematology, Great Ormond Street Hospital, London; the Department of Haematology, the Molecular Immunology Unit and the Molecular Haematology Unit, Institute of Child Health, University College London; the Department of Biochemistry, School of Medical Sciences, University of Bristol; and the Randall Division of Cell and Molecular Biophysics, King's College London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giles O.","family":"Cory","sequence":"additional","affiliation":[{"name":"From the Department of Haematology, Great Ormond Street Hospital, London; the Department of Haematology, the Molecular Immunology Unit and the Molecular Haematology Unit, Institute of Child Health, University College London; the Department of Biochemistry, School of Medical Sciences, University of Bristol; and the Randall Division of Cell and Molecular Biophysics, King's College London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Calle","sequence":"additional","affiliation":[{"name":"From the Department of Haematology, Great Ormond Street Hospital, London; the Department of Haematology, the Molecular Immunology Unit and the Molecular Haematology Unit, Institute of Child Health, University College London; the Department of Biochemistry, School of Medical Sciences, University of Bristol; and the Randall Division of Cell and Molecular Biophysics, King's College London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austen","family":"Worth","sequence":"additional","affiliation":[{"name":"From the Department of Haematology, Great Ormond Street Hospital, London; the Department of Haematology, the Molecular Immunology Unit and the Molecular Haematology Unit, Institute of Child Health, University College London; the Department of Biochemistry, School of Medical Sciences, University of Bristol; and the Randall Division of Cell and Molecular Biophysics, King's College London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Kempski","sequence":"additional","affiliation":[{"name":"From the Department of Haematology, Great Ormond Street Hospital, London; the Department of Haematology, the Molecular Immunology Unit and the Molecular Haematology Unit, Institute of Child Health, University College London; the Department of Biochemistry, School of Medical Sciences, University of Bristol; and the Randall Division of Cell and Molecular Biophysics, King's College London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan","family":"Burns","sequence":"additional","affiliation":[{"name":"From the Department of Haematology, Great Ormond Street Hospital, London; the Department of Haematology, the Molecular Immunology Unit and the Molecular Haematology Unit, Institute of Child Health, University College London; the Department of Biochemistry, School of Medical Sciences, University of Bristol; and the Randall Division of Cell and Molecular Biophysics, King's College London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth E.","family":"Jones","sequence":"additional","affiliation":[{"name":"From the Department of Haematology, Great Ormond Street Hospital, London; the Department of Haematology, the Molecular Immunology Unit and the Molecular Haematology Unit, Institute of Child Health, University College London; the Department of Biochemistry, School of Medical Sciences, University of Bristol; and the Randall Division of Cell and Molecular Biophysics, King's College London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Sinclair","sequence":"additional","affiliation":[{"name":"From the Department of Haematology, Great Ormond Street Hospital, London; the Department of Haematology, the Molecular Immunology Unit and the Molecular Haematology Unit, Institute of Child Health, University College London; the Department of Biochemistry, School of Medical Sciences, University of Bristol; and the Randall Division of Cell and Molecular Biophysics, King's College London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Kinnon","sequence":"additional","affiliation":[{"name":"From the Department of Haematology, Great Ormond Street Hospital, London; the Department of Haematology, the Molecular Immunology Unit and the Molecular Haematology Unit, Institute of Child Health, University College London; the Department of Biochemistry, School of Medical Sciences, University of Bristol; and the Randall Division of Cell and Molecular Biophysics, King's College London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Hann","sequence":"additional","affiliation":[{"name":"From the Department of Haematology, Great Ormond Street Hospital, London; the Department of Haematology, the Molecular Immunology Unit and the Molecular Haematology Unit, Institute of Child Health, University College London; the Department of Biochemistry, School of Medical Sciences, University of Bristol; and the Randall Division of Cell and Molecular Biophysics, King's College London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary E.","family":"Gale","sequence":"additional","affiliation":[{"name":"From the Department of Haematology, Great Ormond Street Hospital, London; the Department of Haematology, the Molecular Immunology Unit and the Molecular Haematology Unit, Institute of Child Health, University College London; the Department of Biochemistry, School of Medical Sciences, University of Bristol; and the Randall Division of Cell and Molecular Biophysics, King's College London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Linch","sequence":"additional","affiliation":[{"name":"From the Department of Haematology, Great Ormond Street Hospital, London; the Department of Haematology, the Molecular Immunology Unit and the Molecular Haematology Unit, Institute of Child Health, University College London; the Department of Biochemistry, School of Medical Sciences, University of Bristol; and the Randall Division of Cell and Molecular Biophysics, King's College London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian J.","family":"Thrasher","sequence":"additional","affiliation":[{"name":"From the Department of Haematology, Great Ormond Street Hospital, London; the Department of Haematology, the Molecular Immunology Unit and the Molecular Haematology Unit, Institute of Child Health, University College London; the Department of Biochemistry, School of Medical Sciences, University of Bristol; and the Randall Division of Cell and Molecular Biophysics, King's College London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111712372558200_REF1","doi-asserted-by":"crossref","unstructured":"Zeidler C, Welte K. Kostmann syndrome and severe congenital neutropenia. Semin Hematol. 2002;39: 82-88.","DOI":"10.1053\/shem.2002.31913"},{"key":"2019111712372558200_REF2","doi-asserted-by":"crossref","unstructured":"Dale DC, Person RE, Bolyard AA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood. 2000;96: 2317-2322.","DOI":"10.1182\/blood.V96.7.2317"},{"key":"2019111712372558200_REF3","doi-asserted-by":"crossref","unstructured":"Ancliff PJ, Gale RE, Linch DC. Neutrophil elastase mutations in congenital neutropenia. Hematology. 2003;8: 165-171.","DOI":"10.1080\/1024533031000107497"},{"key":"2019111712372558200_REF4","doi-asserted-by":"crossref","unstructured":"Ancliff PJ, Gale RE, Watts MJ, et al. Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia. Blood. 2002;100: 707-709.","DOI":"10.1182\/blood-2002-01-0060"},{"key":"2019111712372558200_REF5","doi-asserted-by":"crossref","unstructured":"Devriendt K, Kim AS, Mathijs G, et al. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet. 2001;27: 313-317.","DOI":"10.1038\/85886"},{"key":"2019111712372558200_REF6","doi-asserted-by":"crossref","unstructured":"Burns S, Cory GO, Vainchenker W, Thrasher AJ. Mechanisms of WASp-mediated hematologic and immunologic disease. Blood. 2004;104: 3454-3462.","DOI":"10.1182\/blood-2004-04-1678"},{"key":"2019111712372558200_REF7","doi-asserted-by":"crossref","unstructured":"Notarangelo LD, Ochs HD. WASP and the phenotypic range associated with deficiency. Curr Opin Allergy Clin Immunol. 2005;5: 485-490.","DOI":"10.1097\/01.all.0000191243.25757.ce"},{"key":"2019111712372558200_REF8","doi-asserted-by":"crossref","unstructured":"Higgs HN, Pollard TD. Regulation of actin filament network formation through ARP2\/3 complex: activation by a diverse array of proteins. Annu Rev Biochem. 2001;70: 649-676.","DOI":"10.1146\/annurev.biochem.70.1.649"},{"key":"2019111712372558200_REF9","doi-asserted-by":"crossref","unstructured":"Bompard G, Caron E. Regulation of WASP\/WAVE proteins: making a long story short. J Cell Biol. 2004;166: 957-962.","DOI":"10.1083\/jcb.200403127"},{"key":"2019111712372558200_REF10","doi-asserted-by":"crossref","unstructured":"Kim AS, Kakalis LT, Abdul-Manan N, Liu GA, Rosen MK. Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein. Nature. 2000;404: 151-158.","DOI":"10.1038\/35004513"},{"key":"2019111712372558200_REF11","doi-asserted-by":"crossref","unstructured":"Higgs HN, Pollard TD. Activation by Cdc42 and PIP(2) of Wiskott-Aldrich syndrome protein (WASp) stimulates actin nucleation by Arp2\/3 complex. J Cell Biol. 2000;150: 1311-1320.","DOI":"10.1083\/jcb.150.6.1311"},{"key":"2019111712372558200_REF12","doi-asserted-by":"crossref","unstructured":"Cory GO, Garg R, Cramer R, Ridley AJ. Phosphorylation of tyrosine 291 enhances the ability of WASp to stimulate actin polymerization and filopodium formation. J Biol Chem. 2002;277: 45115-45121.","DOI":"10.1074\/jbc.M203346200"},{"key":"2019111712372558200_REF13","doi-asserted-by":"crossref","unstructured":"Lutskiy MI, Rosen FS, Remold-O'Donnell E. Genotype-proteotype linkage in the Wiskott-Aldrich syndrome. J Immunol. 2005;175: 1329-1336.","DOI":"10.4049\/jimmunol.175.2.1329"},{"key":"2019111712372558200_REF14","doi-asserted-by":"crossref","unstructured":"Jin Y, Mazza C, Christie JR, et al. Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype\/genotype correlation. Blood. 2004;104: 4010-4019.","DOI":"10.1182\/blood-2003-05-1592"},{"key":"2019111712372558200_REF15","doi-asserted-by":"crossref","unstructured":"Imai K, Morio T, Zhu Y, et al. Clinical course of patients with WASP gene mutations. Blood. 2004;103: 456-464.","DOI":"10.1182\/blood-2003-05-1480"},{"key":"2019111712372558200_REF16","doi-asserted-by":"crossref","unstructured":"Thrasher AJ. Wasp in immune-system organization and function. Nat Rev Immunol. 2002;2: 635-646.","DOI":"10.1038\/nri884"},{"key":"2019111712372558200_REF17","doi-asserted-by":"crossref","unstructured":"Ancliff PJ, Gale RE, Liesner R, Hann IM, Linch DC. Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease. Blood. 2001;98: 2645-2650.","DOI":"10.1182\/blood.V98.9.2645"},{"key":"2019111712372558200_REF18","doi-asserted-by":"crossref","unstructured":"Schwartz M, Bekassy A, Donner M, et al. Mutation spectrum in patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia: identification of twelve different mutations in the WASP gene. Thromb Haemost. 1996;75: 546-550.","DOI":"10.1055\/s-0038-1650318"},{"key":"2019111712372558200_REF19","unstructured":"Gale RE, Mein CA, Linch DC. Quantification of X-chromosome inactivation patterns in haematological samples using the DNA PCR-based HUMARA assay. Leukemia. 1996;10: 362-367."},{"key":"2019111712372558200_REF20","unstructured":"Williams DA, Tao W, Yang F, et al. Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency. Blood. 2000;96: 1646-1654."},{"key":"2019111712372558200_REF21","doi-asserted-by":"crossref","unstructured":"Watts MJ, Somervaille TC, Ings SJ, et al. Variable product purity and functional capacity after CD34 selection: a direct comparison of the CliniMACS (v2.1) and Isolex 300i (v2.5) clinical scale devices. Br J Haematol. 2002;118: 117-123.","DOI":"10.1046\/j.1365-2141.2002.03561.x"},{"issue":"pt 4","key":"2019111712372558200_REF22","first-page":"793","volume":"109","year":"1996","journal-title":"J Cell Sci"},{"key":"2019111712372558200_REF23","doi-asserted-by":"crossref","unstructured":"Burns S, Thrasher AJ, Blundell MP, Machesky L, Jones GE. Configuration of human dendritic cell cytoskeleton by Rho GTPases, the WAS protein, and differentiation. Blood. 2001;98: 1142-1149.","DOI":"10.1182\/blood.V98.4.1142"},{"key":"2019111712372558200_REF24","doi-asserted-by":"crossref","unstructured":"Torres E, Rosen MK. Contingent phosphorylation\/dephosphorylation provides a mechanism of molecular memory in WASP. Mol Cell. 2003;11: 1215-1227.","DOI":"10.1016\/S1097-2765(03)00139-4"},{"key":"2019111712372558200_REF25","doi-asserted-by":"crossref","unstructured":"Guinamard R, Aspenstrom P, Fougereau M, Chavrier P, Guillemot JC. Tyrosine phosphorylation of the Wiskott-Aldrich syndrome protein by Lyn and Btk is regulated by CDC42. FEBS Lett. 1998;434: 431-436.","DOI":"10.1016\/S0014-5793(98)01016-3"},{"key":"2019111712372558200_REF26","doi-asserted-by":"crossref","unstructured":"Kolluri R, Tolias KF, Carpenter CL, Rosen FS, Kirchhausen T. Direct interaction of the Wiskott-Aldrich syndrome protein with the GTPase Cdc42. Proc Natl Acad Sci U S A. 1996;93: 5615-5618.","DOI":"10.1073\/pnas.93.11.5615"},{"key":"2019111712372558200_REF27","doi-asserted-by":"crossref","unstructured":"Symons M, Derry JM, Karlak B, et al. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell. 1996;84: 723-734.","DOI":"10.1016\/S0092-8674(00)81050-8"},{"key":"2019111712372558200_REF28","doi-asserted-by":"crossref","unstructured":"Nicklas RB. How cells get the right chromosomes. Science. 1997;275: 632-637.","DOI":"10.1126\/science.275.5300.632"},{"key":"2019111712372558200_REF29","doi-asserted-by":"crossref","unstructured":"Ou YY, Rattner JB. Post-karyokinesis centrosome movement leaves a trail of unanswered questions. Cell Motil Cytoskeleton. 2002;51: 123-132.","DOI":"10.1002\/cm.10019"},{"key":"2019111712372558200_REF30","doi-asserted-by":"crossref","unstructured":"Gachet Y, Tournier S, Millar JB, Hyams JS. A MAP kinase-dependent actin checkpoint ensures proper spindle orientation in fission yeast. Nature. 2001;412: 352-355.","DOI":"10.1038\/35085604"},{"key":"2019111712372558200_REF31","doi-asserted-by":"crossref","unstructured":"Pelham RJ, Chang F. Actin dynamics in the contractile ring during cytokinesis in fission yeast. Nature. 2002;419: 82-86.","DOI":"10.1038\/nature00999"},{"key":"2019111712372558200_REF32","doi-asserted-by":"crossref","unstructured":"Alter BP, Caruso JP, Drachtman RA, et al. Fanconi anemia: myelodysplasia as a predictor of outcome. Cancer Genet Cytogenet. 2000;117: 125-131.","DOI":"10.1016\/S0165-4608(99)00159-4"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/108\/7\/2182\/1283426\/zh801906002182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/108\/7\/2182\/1283426\/zh801906002182.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T17:37:45Z","timestamp":1574012265000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/108\/7\/2182\/22465\/Two-novel-activating-mutations-in-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,1]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,10,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2006-01-010249","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,1]]}}}